• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用烟曲霉感染家蚕模型发现新型抗真菌剂ASP2397

Discovery of a new antifungal agent ASP2397 using a silkworm model of Aspergillus fumigatus infection.

作者信息

Nakamura Ikuko, Kanasaki Ryuichi, Yoshikawa Koji, Furukawa Shigetada, Fujie Akihiko, Hamamoto Hiroshi, Sekimizu Kazuhisa

机构信息

Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan.

Teikyo University Institute of Medical Mycology, Tokyo, Japan.

出版信息

J Antibiot (Tokyo). 2017 Jan;70(1):41-44. doi: 10.1038/ja.2016.106. Epub 2016 Aug 31.

DOI:10.1038/ja.2016.106
PMID:27577982
Abstract

Natural products are the major source of currently available drugs. However, screening natural product presents several challenges, including the time-consuming and labor-intensive steps required for the isolation of a drug from crude extracts as well as the differences between the activities of compounds in vitro and in vivo. To address these challenges, we used silkworm larvae infected with Aspergillus fumigatus to screen a natural products library for potent drugs to treat invasive aspergillosis. A rationally designed library was constructed using numerous, geographically diverse fungal species and then screened to collect extracts of microorganisms that had detectable anti-Aspergillus activity. We evaluated this library using cultures of A. fumigatus and a silkworm model system of A. fumigatus infection. With this model, we identified the novel antifungal compound ASP2397 that not only cured infected silkworm larvae but also increased the rates of survival of mice infected with A. fumigatus. These findings strongly support the utility of the silkworm screening system for the simple and rapid isolation of antibiotics from natural products libraries.

摘要

天然产物是目前可用药物的主要来源。然而,筛选天然产物存在若干挑战,包括从粗提物中分离药物所需的耗时且费力的步骤,以及化合物体外和体内活性的差异。为应对这些挑战,我们利用感染烟曲霉的家蚕幼虫来筛选天然产物文库,以寻找治疗侵袭性曲霉病的有效药物。使用多种地理来源不同的真菌构建了一个经过合理设计的文库,然后进行筛选,收集具有可检测到的抗曲霉活性的微生物提取物。我们使用烟曲霉培养物和烟曲霉感染的家蚕模型系统对该文库进行了评估。通过这个模型,我们鉴定出了新型抗真菌化合物ASP2397,它不仅治愈了受感染的家蚕幼虫,还提高了感染烟曲霉的小鼠的存活率。这些发现有力地支持了家蚕筛选系统在从天然产物文库中简单快速分离抗生素方面的实用性。

相似文献

1
Discovery of a new antifungal agent ASP2397 using a silkworm model of Aspergillus fumigatus infection.利用烟曲霉感染家蚕模型发现新型抗真菌剂ASP2397
J Antibiot (Tokyo). 2017 Jan;70(1):41-44. doi: 10.1038/ja.2016.106. Epub 2016 Aug 31.
2
ASP2397 Is a Novel Natural Compound That Exhibits Rapid and Potent Fungicidal Activity against Species through a Specific Transporter.ASP2397 是一种新型天然化合物,通过特定转运蛋白对 种真菌表现出快速而强效的杀菌活性。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.02689-18. Print 2019 Oct.
3
Silkworm fungal infection model for identification of virulence genes in pathogenic fungus and screening of novel antifungal drugs.用于鉴定致病真菌毒力基因和筛选新型抗真菌药物的家蚕真菌感染模型。
Drug Discov Ther. 2017 Mar 22;11(1):1-5. doi: 10.5582/ddt.2016.01080. Epub 2017 Feb 21.
4
The quinoline bromoquinol exhibits broad-spectrum antifungal activity and induces oxidative stress and apoptosis in Aspergillus fumigatus.喹啉溴喹啉具有广谱抗真菌活性,并能诱导烟曲霉产生氧化应激和凋亡。
J Antimicrob Chemother. 2017 Aug 1;72(8):2263-2272. doi: 10.1093/jac/dkx117.
5
Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF.实验性系统性小鼠曲霉病:两性霉素与卡泊芬净联合及粒细胞集落刺激因子治疗
J Antimicrob Chemother. 2005 Sep;56(3):594-7. doi: 10.1093/jac/dki252. Epub 2005 Jul 8.
6
[Development of Antibiotics Using Silkworm Bacteria and Fungi Infection Model].[利用家蚕细菌和真菌感染模型开发抗生素]
Yakugaku Zasshi. 2018;138(7):895-899. doi: 10.1248/yakushi.17-00202-4.
7
FR901469, a novel antifungal antibiotic from an unidentified fungus No.11243. II. In vitro and in vivo activities.FR901469,一种源自未鉴定真菌No.11243的新型抗真菌抗生素。II. 体外和体内活性。
J Antibiot (Tokyo). 2000 Sep;53(9):920-7. doi: 10.7164/antibiotics.53.920.
8
Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.米卡芬净(FK463)对一株耐伊曲康唑的烟曲霉以及一株对两性霉素B表现出体内耐药性的土曲霉的活性。
J Antimicrob Chemother. 2003 Apr;51(4):913-9. doi: 10.1093/jac/dkg185. Epub 2003 Mar 13.
9
In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis. EBGA Network. European research group on Biotypes and Genotypes of Aspergillus fumigatus.系统性小鼠曲霉病中烟曲霉对体内伊曲康唑的耐药性。EBGA网络。烟曲霉生物型和基因型欧洲研究小组。
J Med Microbiol. 1999 Dec;48(12):1087-1093. doi: 10.1099/00222615-48-12-1087.
10
Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.在感染烟曲霉的大鼠中,评估阿贝西普和两性霉素B脂质体与卡泊芬净联合给药后两性霉素B的抗真菌活性、药代动力学和组织分布。
J Pharm Sci. 2007 Jul;96(7):1737-47. doi: 10.1002/jps.20801.

引用本文的文献

1
Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects.新一代抗真菌药物:作用机制、疗效及临床前景。
Acta Pharm Sin B. 2025 Aug;15(8):3852-3887. doi: 10.1016/j.apsb.2025.06.013. Epub 2025 Jun 23.
2
The silkworm: A promising invertebrate diabetes model for natural drug discovery.家蚕:一种用于天然药物发现的有前景的无脊椎动物糖尿病模型。
Glob Health Med. 2025 Jun 30;7(3):199-210. doi: 10.35772/ghm.2025.01067.
3
Discovery of new AMR drugs targeting modulators of antimicrobial activity using in vivo silkworm screening systems.

本文引用的文献

1
ASP2397: a novel antifungal agent produced by Acremonium persicinum MF-347833.ASP2397:一种由桃色顶孢霉MF-347833产生的新型抗真菌剂。
J Antibiot (Tokyo). 2017 Jan;70(1):45-51. doi: 10.1038/ja.2016.107. Epub 2016 Sep 7.
2
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.赖氨酸素 E 是一种新型抗生素,作用靶点是细菌膜中的menaquinone。
Nat Chem Biol. 2015 Feb;11(2):127-33. doi: 10.1038/nchembio.1710. Epub 2014 Dec 8.
3
Pharmacology and clinical use of voriconazole.伏立康唑的药理学与临床应用。
利用体内家蚕筛选系统发现靶向抗菌活性调节剂的新型抗菌药物耐药性药物
J Antibiot (Tokyo). 2025 Jan;78(2):69-77. doi: 10.1038/s41429-024-00788-2. Epub 2024 Nov 14.
4
Advancements and challenges in antifungal therapeutic development.抗真菌治疗药物研发的进展与挑战。
Clin Microbiol Rev. 2024 Mar 14;37(1):e0014223. doi: 10.1128/cmr.00142-23. Epub 2024 Jan 31.
5
efficacy of pitavastatin combined with itraconazole against in silkworm models.匹伐他汀联合伊曲康唑在家蚕模型中的疗效
Microbiol Spectr. 2023 Sep 1;11(5):e0266623. doi: 10.1128/spectrum.02666-23.
6
Silkworm model of biofilm formation: In vivo evaluation of antimicrobial tolerance of a cross-kingdom dual-species (Escherichia coli and Candida albicans) biofilm on catheter material.家蚕生物膜形成模型:对导管材料上跨王国双物种(大肠杆菌和白色念珠菌)生物膜的抗微生物药物耐受性的体内评估。
PLoS One. 2023 Jul 14;18(7):e0288452. doi: 10.1371/journal.pone.0288452. eCollection 2023.
7
Elucidating the molecular programming of a nonlinear non-ribosomal peptide synthetase responsible for fungal siderophore biosynthesis.阐明负责真菌铁载体生物合成的非线性非核糖体肽合成酶的分子编程。
Nat Commun. 2023 May 17;14(1):2832. doi: 10.1038/s41467-023-38484-8.
8
GR-2397: Review of the Novel Siderophore-like Antifungal Agent for the Treatment of Invasive Aspergillosis.GR - 2397:用于治疗侵袭性曲霉病的新型铁载体样抗真菌药物综述
J Fungi (Basel). 2022 Aug 27;8(9):909. doi: 10.3390/jof8090909.
9
A Infection Model for Screening Antibiotics against .一种用于筛选抗……抗生素的感染模型。 (原文“against”后内容缺失)
Insects. 2022 Aug 19;13(8):748. doi: 10.3390/insects13080748.
10
Therapeutic Approaches for Combating Associated Infection.对抗相关感染的治疗方法。
Curr Drug Targets. 2022;23(16):1465-1488. doi: 10.2174/1389450123666220623164548.
Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):83-94. doi: 10.1517/17425250903463878.
4
Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds.使用基于血清的抗真菌药敏试验来预测新型棘白菌素类化合物的体内疗效。
Microbiol Immunol. 2008 Aug;52(8):383-91. doi: 10.1111/j.1348-0421.2008.00053.x.
5
Quantitative evaluation of the therapeutic effects of antibiotics using silkworms infected with human pathogenic microorganisms.利用感染人类致病微生物的家蚕对抗生素治疗效果进行定量评估。
Antimicrob Agents Chemother. 2004 Mar;48(3):774-9. doi: 10.1128/AAC.48.3.774-779.2004.
6
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.非清髓性预处理后异基因造血干细胞移植受者侵袭性真菌感染的风险与结局
Blood. 2003 Aug 1;102(3):827-33. doi: 10.1182/blood-2003-02-0456. Epub 2003 Apr 10.
7
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.伏立康唑与两性霉素B用于侵袭性曲霉病的初始治疗比较
N Engl J Med. 2002 Aug 8;347(6):408-15. doi: 10.1056/NEJMoa020191.
8
Silkworm larvae as an animal model of bacterial infection pathogenic to humans.家蚕幼虫作为对人类致病的细菌感染动物模型。
Microb Pathog. 2002 Apr;32(4):183-90. doi: 10.1006/mpat.2002.0494.
9
Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution.血液学患者侵袭性肺曲霉病的管理:单机构87例连续病例回顾
Clin Infect Dis. 2000 Oct;31(4):859-68. doi: 10.1086/318133. Epub 2000 Oct 10.
10
In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.新型脂肽抗真菌剂FK463对多种临床重要真菌的体外活性
Antimicrob Agents Chemother. 2000 Jan;44(1):57-62. doi: 10.1128/AAC.44.1.57-62.2000.